Research of hepatitis a virus antibodies in children 0-18 aged in the province of Erzurum, Turkey

AbstractAim: The aim of the study was to compare the anti-HAV IgG and Anti-HAV IgM seropositivity in children aged 0-18 in Erzurum with studies in our country and other countries, and also to evaluate the effect of seasons on hepatitis A infection.Material and Methods: The study was conducted on the serum samples of 5086 patients aged 0-18 years, who were considered to have Hepatitis A or who applied with different complaints as a result of the examination of family physicians in Erzurum between 2015 and 2018. The results of these patients, obtained from Anti-HAV IgM and Anti-HAV IgG analysis by ELISA method in the Public Health Microbiology Laboratory, were evaluated retrospectively. Pearson chi-square test was used to analyze the categorical data such as gender, age and seasonal differences in anti-HAV IgM and Anti-HAV IgG positivity rates and p

PDF

___

1. Jorgensen JH, Pfaller MA. Manual of Clinical Microbiology. In: Anderson DA, Counihan NA, eds. Hepatitis A and E. 11th edition. Washington: ASM Press 2015;1584-98.
2. Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis 2015;28:488-96.
3. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010;2841:6653-7.
4. Brundage SC, Fitzpatrick AN. Hepatitis A. Am Fam Physician 2006;73:2162-8.
5. Carrillo-Santisteve P, Tavoschi L, Severi E, et al. Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review. Lancet Infect Dis 2017;1710:306- 19.
6. Mehr AJ, Ardakani MJE, Hedayati M, et al. Agespecific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol 2004;19:275-8.
7. Sac RU, Bostancı I, Dallar Y, et al. Hepatitis A seroprevalence and demographics in Turkish children in Ankara. Pediatr Int 2009;51:5-8.
8. Tosun S, Ertan P, Kasirga E, et al. Changes in seroprevalence of hepatitis A in children and adolescents in Manisa, Turkey. Pediat int 2004;46:669- 72.
9. Kim HY, Eyheramonho MB, Pichavant M, et al. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest 2011;121:1111-8.
10. Lankarani KB, Mahmoodi M, Honarvar B, et al. Determinants of poor outcome in patients with hepatitis A infection: a four-year retrospective study in Shiraz, Southern Iran. Arch Virol 2014;159:1901-7.
11. Balamtekin N, Kalman S, Unay B, et al. Seroprevalence of hepatitis A in children living in the region of Kayseri. Gulhane Med J 2006;48:142-5.
12. Ozaras R, Arends JE. Viral Hepatitis. In: Turse EP, Rassow B, Tahan V, eds. Acute Hepatitis A. Chom: Springer Nature Switzerland AG 2019; 17-24.
13. World Heath Organization (WHO) Hepatitis A. https:// www.who.int/news-room/fact-sheets/detail/ hepatitis-a access date 19.09.2018
14. Gul HC, Avcı IY, Coskun O, et al. Anti-HAV seroprevalence in Turkish military personnel and its relation with demographic properties. Turk J Med Sci 2009;39:795-802.
15. Tekay F. Hepatitis a Frequency in Children of Between 0–14 Age Group who Had Consulted At Hakkari Province Hospital. Dicle Med J 2006;33:245-7.
16. Copur Cicek A, Ozkasap S, Dereci S, et al. Seroprevelance of HAV, HBV, HCV in Pediatric Patients in Rize City. Viral Hepat J 2012;18:102-6
17. Arvas G, Kaya B, Berktas M. The Seroprevalance of Acute Hepatitis A in 0-18 Age Group Children who Applied to Igdir State Hospital. J Pediatr Inf 2011;5:129.
18. Garcia-Juarez I, Solórzano Santos F, Álvarez MT, et al. Is there a shift in the epidemiology of hepatitis A in Mexican children? Rev Invest Clin 2008;60:292-6.
19. Rath C, Akki A, Patil S, et al. Seroprevalence of hepatitis A virus antibody in Bijapur, Karnataka. Indian pediatr 2011;48:71-3.
20. Jablonka A, Solbach P, Happle C, et al. Hohe HepatitisA-Immunitätsrate bei Flüchtlingen in Deutschland. Med Klin Intensivmed Notfmed 2017;112:347-51.
21. Republic of Turkey Ministry of Health, Hepatitis A vaccine application letter 02 June 2012. https://dosyaism. saglik.gov.tr/Eklenti/12472,20121008-1509 access date 02.06.2019
22. Arabaci F, Oldacay M. The Seroprevalence of Hepatitis A in Different Age Groups and Hepatitis A Incidence in Acute Hepatitis Cases in The Canakkale Province. J Pediatr Inf 2009;3:58-61.
23. Duran I, Nazik S. Seroprevalence of Hepatitis A in Pediatric Age Groups in Bingöl Province. JAREM. 2018;8:15-8.
24. Yan BY, Lv JJ, Liu JY, et al. Changes in seroprevalence of hepatitis A after the implementation of universal children vaccination in Shandong Province, China: a comparison between 2006 and 2014. Int J Infect Dis 2019;82:129-34.
25. Badur S. Viral hepatitler (HAV, HBV, HDV). In: Ustacelebi S, Abacıoglu H, Badur S, eds. Moleküler, Klinik ve Tanısal Viroloji. Ankara: Gunes Kitabevi; 2004;175- 202.
26. Parlak M, Cikman A, Guducuoglu H, et al. Distribution of anti-HAV IgM positivity according to age and months of a year in Van region, Turkey. Dicle Med J 2012;39:398-402.
27. Yilmaz Y, Ustebay S, Tazegun Z, et al. The seropositivity of Hepatitis A in children aged between 0-18 years in Kars province and around. Dicle Med J 2015;42:315- 8.
28. Papatya ED, Olgun T, Ekici M, Urganci N, Ozcelik G, CakirD. Seroprevalance of Hepatitis A in children between 2 and 15 years old. ŞEH Tip Bulteni 2004;38:19-23.
29. Isilar GFG, Uysal G, Arhan E, Kibar AE, Vidinlisan S, Oskovi H. Determination of Hepatitis A seroprevalence and risk factors in childhood. Turkiye Klinikleri J Pediatr 2010;19:113-7.
30. Ozen M, Yologlu S, Isik Y, et al. Anti-HAV IgG seropositivity in children aged between 2-16 years who were admitted to Turgut Ozal Medical Center. Turk Pediatri Ars 2006;41:36-40.
31. Kalem F, Erayman B, Yuksekkaya S, et al. The seroepidemiology of Hepatitis A in Konya. Viral Hepat J 2013;19:19-22.
32. Turker K, Balci E, Batı S, et al. In our country, the changing epidemiology of Hepatitis A infection. Turk Mikrobiyol Cem Derg 2011; 41: 143-8.
33. Halicioglu O, Akman SA, Tatar B, et al. Hepatitis A seroprevalence in children and adolescents aged 1–18 years among a low socioeconomic population in Izmir, Turkey. J Travel Med 2012;10:43-7.
34. Dogan E, Sevinç E, Cüneyt K. Seroprevalence of HAV, HBV, and HCV in pediatric patients in Karabuk province. The Turkish Journal of Academic Gastroenterology 2017;16:97-100.
35. Kolancali N, Onal ZE, Aksaray S, et al. Evaluation of the seroprevalence of Hepatit A and vaccination status in children aged two and sixteen years. Viral Hepat J 2017;23:46-9.
36. Calık S, Tosun S, Arı A, et al. Hepatitis A seroprevalence in fifferent age groups in a region with low and moderate socioeconomic level in Izmir province: Results of a fieldwork. Klimik Derg 2019;32:310-4.